Differences in clinical and laboratory findings between VER and non-VER patients after 3 months of TRB treatment.
. | VER . | Non-VER . | P . |
---|---|---|---|
N | 17 | 20 | |
Male/female | 13/4 | 13/7 | .45 |
Age (years) | 45.5 ± 13.73 | 52.36 ± 12.95 | .2 |
SBP (mmHg) T3 | 128.33 ± 10.41 | 126.5 ± 8.18 | .84 |
DBP (mmHg) T3 | 76.67 ± 5.77 | 76 ± 10.49 | .98 |
Smoking habits (n) | 11 | 15 | .97 |
BMI (kg/m2) | 25.32 ± 2.98 | 26.00 ± 3.86 | .55 |
Statin administration (n) | 8 | 18 | .23 |
Time since diagnosis (months) | 29.41 ± 6.96 | 65.37 ± 17.64 | .05 |
eGFR Tbx (mL/min/1.73 m2) | 70.6 ± 24.74 | 52.46 ± 16.35 | .05 |
eGFR T0 (mL/min/1.73 m2) | 67.96 ± 21.98 | 48.05 ± 19.24 | .01 |
Uprot Tbx (g/24 h) | 3.64 ± 2.37 | 2.15 ± 1.24 | .05 |
Uprot T0 (g/24 h) | 2.67 ± 1.61 | 2.96 ± 1.69 | .66 |
UPCR Tbx (g/g) | 3.86 ± 0.68 | 1.83 ± 1.14 | .02 |
UPCR T0 (g/g) | 2.26 ± 0.54 | 1.89 ± 0.2 | .66 |
. | VER . | Non-VER . | P . |
---|---|---|---|
N | 17 | 20 | |
Male/female | 13/4 | 13/7 | .45 |
Age (years) | 45.5 ± 13.73 | 52.36 ± 12.95 | .2 |
SBP (mmHg) T3 | 128.33 ± 10.41 | 126.5 ± 8.18 | .84 |
DBP (mmHg) T3 | 76.67 ± 5.77 | 76 ± 10.49 | .98 |
Smoking habits (n) | 11 | 15 | .97 |
BMI (kg/m2) | 25.32 ± 2.98 | 26.00 ± 3.86 | .55 |
Statin administration (n) | 8 | 18 | .23 |
Time since diagnosis (months) | 29.41 ± 6.96 | 65.37 ± 17.64 | .05 |
eGFR Tbx (mL/min/1.73 m2) | 70.6 ± 24.74 | 52.46 ± 16.35 | .05 |
eGFR T0 (mL/min/1.73 m2) | 67.96 ± 21.98 | 48.05 ± 19.24 | .01 |
Uprot Tbx (g/24 h) | 3.64 ± 2.37 | 2.15 ± 1.24 | .05 |
Uprot T0 (g/24 h) | 2.67 ± 1.61 | 2.96 ± 1.69 | .66 |
UPCR Tbx (g/g) | 3.86 ± 0.68 | 1.83 ± 1.14 | .02 |
UPCR T0 (g/g) | 2.26 ± 0.54 | 1.89 ± 0.2 | .66 |
Data are presented as mean ± standard deviation or n.
SBP, systolic BP; DBP, diastolic BP.
Differences in clinical and laboratory findings between VER and non-VER patients after 3 months of TRB treatment.
. | VER . | Non-VER . | P . |
---|---|---|---|
N | 17 | 20 | |
Male/female | 13/4 | 13/7 | .45 |
Age (years) | 45.5 ± 13.73 | 52.36 ± 12.95 | .2 |
SBP (mmHg) T3 | 128.33 ± 10.41 | 126.5 ± 8.18 | .84 |
DBP (mmHg) T3 | 76.67 ± 5.77 | 76 ± 10.49 | .98 |
Smoking habits (n) | 11 | 15 | .97 |
BMI (kg/m2) | 25.32 ± 2.98 | 26.00 ± 3.86 | .55 |
Statin administration (n) | 8 | 18 | .23 |
Time since diagnosis (months) | 29.41 ± 6.96 | 65.37 ± 17.64 | .05 |
eGFR Tbx (mL/min/1.73 m2) | 70.6 ± 24.74 | 52.46 ± 16.35 | .05 |
eGFR T0 (mL/min/1.73 m2) | 67.96 ± 21.98 | 48.05 ± 19.24 | .01 |
Uprot Tbx (g/24 h) | 3.64 ± 2.37 | 2.15 ± 1.24 | .05 |
Uprot T0 (g/24 h) | 2.67 ± 1.61 | 2.96 ± 1.69 | .66 |
UPCR Tbx (g/g) | 3.86 ± 0.68 | 1.83 ± 1.14 | .02 |
UPCR T0 (g/g) | 2.26 ± 0.54 | 1.89 ± 0.2 | .66 |
. | VER . | Non-VER . | P . |
---|---|---|---|
N | 17 | 20 | |
Male/female | 13/4 | 13/7 | .45 |
Age (years) | 45.5 ± 13.73 | 52.36 ± 12.95 | .2 |
SBP (mmHg) T3 | 128.33 ± 10.41 | 126.5 ± 8.18 | .84 |
DBP (mmHg) T3 | 76.67 ± 5.77 | 76 ± 10.49 | .98 |
Smoking habits (n) | 11 | 15 | .97 |
BMI (kg/m2) | 25.32 ± 2.98 | 26.00 ± 3.86 | .55 |
Statin administration (n) | 8 | 18 | .23 |
Time since diagnosis (months) | 29.41 ± 6.96 | 65.37 ± 17.64 | .05 |
eGFR Tbx (mL/min/1.73 m2) | 70.6 ± 24.74 | 52.46 ± 16.35 | .05 |
eGFR T0 (mL/min/1.73 m2) | 67.96 ± 21.98 | 48.05 ± 19.24 | .01 |
Uprot Tbx (g/24 h) | 3.64 ± 2.37 | 2.15 ± 1.24 | .05 |
Uprot T0 (g/24 h) | 2.67 ± 1.61 | 2.96 ± 1.69 | .66 |
UPCR Tbx (g/g) | 3.86 ± 0.68 | 1.83 ± 1.14 | .02 |
UPCR T0 (g/g) | 2.26 ± 0.54 | 1.89 ± 0.2 | .66 |
Data are presented as mean ± standard deviation or n.
SBP, systolic BP; DBP, diastolic BP.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.